These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 37851478

  • 1. Influence of Primary Tumor Resection on Survival of Patients With Metastatic Siewert Type II Adenocarcinoma of the Esophagogastric Junction: A Population-Based, Propensity-Matched Analysis.
    Chen J, Jia X, Chen H, Cai J, Chen L.
    Cancer Control; 2023; 30():10732748231208313. PubMed ID: 37851478
    [Abstract] [Full Text] [Related]

  • 2. Clinical significance of lower perigastric lymph nodes dissection in Siewert type II/III adenocarcinoma of esophagogastric junction: a retrospective propensity score matched study.
    Li ZL, Zhao LY, Zhang WH, Liu K, Pang HY, Chen XL, Chen XZ, Yang K, Hu JK.
    Langenbecks Arch Surg; 2022 May; 407(3):985-998. PubMed ID: 34792614
    [Abstract] [Full Text] [Related]

  • 3. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
    Yang S, Yuan Y, Hu H, Li R, Liu K, Zhang W, Yang K, Yang Y, Bai D, Chen X, Zhou Z, Chen L.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb 25; 22(2):132-142. PubMed ID: 30799535
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
    Zhu Z, Wang Y, Li F, Gao J, Han B, Wang R, Xue Y.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb 25; 22(2):149-155. PubMed ID: 30799537
    [Abstract] [Full Text] [Related]

  • 12. Sites of distant metastases and the cancer-specific survival of metastatic Siewert type II esophagogastric junction adenocarcinoma: a population-based study.
    Chen K, Deng X, Yang Z, Yu D, Zhang X, Li W, Xie D, He Z, Cheng D.
    Expert Rev Gastroenterol Hepatol; 2020 Jun 25; 14(6):491-497. PubMed ID: 32324423
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Lymph Node Ratio Is an Independent Prognostic Factor for Patients with Siewert Type II Adenocarcinoma of Esophagogastric Junction: Results from a 10-Year Follow-up Study.
    Zhang Y, Liu D, Zeng D, Chen C.
    J Gastrointest Cancer; 2021 Sep 25; 52(3):983-992. PubMed ID: 32954465
    [Abstract] [Full Text] [Related]

  • 15. Proximal Gastrectomy versus Total Gastrectomy for Siewert Type II Adenocarcinoma of the Esophagogastric Junction: A Comprehensive Analysis of Data from the SEER Registry.
    Zhu K, Xu Y, Fu J, Mohamud FA, Duan Z, Tan S, Zhao Z, Chen P, Zong L.
    Dis Markers; 2019 Sep 25; 2019():9637972. PubMed ID: 31976023
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Can Clinical Stage in the 8th Edition of the Union for International Cancer Control TNM Classification Stratify the Prognosis of Patients Undergoing Curative Surgery for Siewert Type II/III Adenocarcinoma of the Esophagogastric Junction?
    Watanabe H, Hasegawa S, Kumazu Y, Hashimoto I, Komori K, Suematsu H, Kano K, Fujikawa H, Aoyama T, Yamada T, Yukawa N, Yoshikawa T, Rino Y, Saito A, Ogata T, Oshima T.
    In Vivo; 2023 Sep 25; 37(4):1790-1796. PubMed ID: 37369497
    [Abstract] [Full Text] [Related]

  • 20. [Comparison of the superiority of different TNM staging systems in Siewert III adenocarcinoma of esophagogastric junction].
    Lu Y, Xi H, Xie T, Qiu Z, Wang X, Wei B, Chen L.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb 25; 22(2):143-148. PubMed ID: 30799536
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.